Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage.

Meyer R, Deem S, Yanez ND, Souter M, Lam A, Treggiari MM.

Neurocrit Care. 2011 Feb;14(1):24-36. doi: 10.1007/s12028-010-9437-z.

PMID:
20838932
2.

"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.

Lee KH, Lukovits T, Friedman JA.

Neurocrit Care. 2006;4(1):68-76. Review.

PMID:
16498198
3.

Hemodynamic management of subarachnoid hemorrhage.

Treggiari MM; Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage..

Neurocrit Care. 2011 Sep;15(2):329-35. doi: 10.1007/s12028-011-9589-5. Review.

PMID:
21786046
4.

Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.

Ekelund A, Reinstrup P, Ryding E, Andersson AM, Molund T, Kristiansson KA, Romner B, Brandt L, Säveland H.

Acta Neurochir (Wien). 2002 Jul;144(7):703-12; discussion 712-3.

PMID:
12181704
5.

Triple H therapy after aneurysmal subarachnoid hemorrhage. A review.

Romner B, Reinstrup P.

Acta Neurochir Suppl. 2001;77:237-41. Review. No abstract available.

PMID:
11563296
6.

Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.

Muench E, Horn P, Bauhuf C, Roth H, Philipps M, Hermann P, Quintel M, Schmiedek P, Vajkoczy P.

Crit Care Med. 2007 Aug;35(8):1844-51; quiz 1852.

PMID:
17581487
7.

Effect of triple-h prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage.

Tagami T, Kuwamoto K, Watanabe A, Unemoto K, Yokobori S, Matsumoto G, Igarashi Y, Yokota H; SAH PiCCO Study Group..

Neurocrit Care. 2014 Dec;21(3):462-9. doi: 10.1007/s12028-014-9973-z.

PMID:
24865266
8.

Which H is the most important in triple-H therapy for cerebral vasospasm?

Treggiari MM, Deem S.

Curr Opin Crit Care. 2009 Apr;15(2):83-6. doi: 10.1097/MCC.0b013e32832922d1. Review.

PMID:
19276798
9.

Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.

Origitano TC, Wascher TM, Reichman OH, Anderson DE.

Neurosurgery. 1990 Nov;27(5):729-39; discussion 739-40.

PMID:
2259403
10.

Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage?

Capampangan DJ, Wellik KE, Aguilar MI, Demaerschalk BM, Wingerchuk DM.

Neurologist. 2008 Nov;14(6):395-8. doi: 10.1097/NRL.0b013e31818a0f29. Review.

PMID:
19008746
11.

[Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].

Romero Kräuchi O, Verger Bennasar AM.

Rev Esp Anestesiol Reanim. 2011 Apr;58(4):230-5. Review. Spanish.

PMID:
21608279
12.

Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984, May, 2003.

Egge A, Waterloo K, Sjøholm H, Solberg T, Ingebrigtsen T, Romner B.

J Neurosurg. 2004 Feb;100(2):359-60; author reply 360. No abstract available.

PMID:
15086250
13.

Cerebral vasospasm after subarachnoid hemorrhage: hypertensive hypervolemic hemodilution (triple-H) therapy according to new systemic hemodynamic parameters.

Krayenbühl N, Hegner T, Yonekawa Y, Keller E.

Acta Neurochir Suppl. 2001;77:247-50. No abstract available.

PMID:
11563298
14.

Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.

Liu-Deryke X, Rhoney DH.

Pharmacotherapy. 2006 Feb;26(2):182-203. Review.

PMID:
16466324
15.

Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm after subarachnoid hemorrhage.

Qureshi AI, Suarez JI, Bhardwaj A, Yahia AM, Tamargo RJ, Ulatowski JA.

Crit Care Med. 2000 Mar;28(3):824-9.

PMID:
10752836
16.

Value of triple H therapy in a patient with an ischemic penumbra following subarachnoid hemorrhage: a case study.

Ogungbo B, Prakash S, Ushewokunze S, Etherson K, Sinar J.

J Neurosci Nurs. 2005 Dec;37(6):326-8, 333.

PMID:
16396086
17.

Routine management of volume status after aneurysmal subarachnoid hemorrhage.

Wolf S; Participants in the International Multi-Disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage..

Neurocrit Care. 2011 Sep;15(2):275-80. doi: 10.1007/s12028-011-9593-9. Review.

PMID:
21748500
18.

[Recommendations for the management of patients with aneurysmal subarachnoid hemorrhage].

Raabe A, Beck J, Berkefeld J, Deinsberger W, Meixensberger J, Schmiedek P, Seifert V, Steinmetz H, Unterberg A, Vajkoczy P, Werner C; Deutschen Gesellschaft für Anästhesiologie und Intensivmedizin..

Zentralbl Neurochir. 2005 May;66(2):79-91. Review. German.

PMID:
15846536
19.

Cerebral vasospasm after subarachnoid hemorrhage: an update.

Kosty T.

Crit Care Nurs Q. 2005 Apr-Jun;28(2):122-34.

PMID:
15875443
20.

[Intensive care using hypervolemic hypertensive hemodilution in the acute period of subarachnoidal hemorrhages in patients with arterial aneurysms].

Kurdiumova NV, Parfenov AL, Fokin MS, Grinenko EA, Eliava ShSh, Kheĭreddin AS, Sazonov IA.

Zh Vopr Neirokhir Im N N Burdenko. 2006 Apr-Jun;(2):48-53. Russian.

PMID:
16827430

Supplemental Content

Support Center